United States: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

M&A In A Period Of Turbulence

Macroeconomic volatility, shifting trade policies, and regulatory change continue to shape the dealmaking landscape. Here we explore the challenges and opportunities for buyers and sellers navigating uncertain markets.

Worldwide Commercial

AO

A&O Shearman

Office Of Inspector General Highlights Flat Fee Structures Not Immune From Anti-Kickback Statute

The U.S. Department of Health and Human Services Office of Inspector General (OIG) published Advisory Opinion 25-08 (Opinion) on July 7, 2025...

United States Healthcare

HK

Holland & Knight

No Moratorium On State AI Laws In The Federal Budget Bill: Implications For Healthcare And Life Sciences Industry

With the signing of the budget and tax bill—also known as the "One Big Beautiful Bill Act"—by President Trump on July 4, 2025, the federal government has decided that it will not attempt to preempt various state efforts...

United States Healthcare

WS

Winston & Strawn LLP

"False Claims Act Working Group" Signals Aggressive FCA Enforcement In Health Care And Life Sciences

Further demonstrating its interest in ramping up anti-fraud enforcement in the health care and life sciences industries, on July 2, 2025, the U.S. Department of Justice (DOJ)...

United States Healthcare

AP

Arnold & Porter

APHIS Seeks Comment On Draft Environmental Documents For Deregulation Of American Chestnut Developed Using Genetic Engineering

United States Environment

BC

Bergeson & Campbell

DOJ And HHS Launch FCA Working Group: Heightened Enforcement Risk For Health Care Entities

United States Healthcare

CM

Crowell & Moring LLP

A Look Ahead In Life Sciences: What We Are Tracking In The Third Quarter Of 2025 And Beyond

United States Healthcare

GP

Goodwin Procter LLP

DOJ And HHS Announce New False Claims Act Working Group

United States Healthcare

W

WilmerHale

One Big Beautiful Bill Act – Tax Implications For Life Sciences Industry

United States Tax

GP

Goodwin Procter LLP

The European Court Of Justice Rules That Poland's Laws Prohibiting Pharmacies From Advertising Are Overly Restrictive

United States Media & IT

AP

Arnold & Porter

NSCEB Seeks Input To Modernize Biotechnology Product Regulation

United States Healthcare

BC

Bergeson & Campbell

Gender-Affirming Care: What The Supreme Court's Ruling In Skrmetti Means For Health Care Providers Nationwide

United States Healthcare

FL

Foley & Lardner

OIG Declines To Approve Medical Device Company's Proposal To Subsidize Screening Costs

United States Healthcare

BB

Bass, Berry & Sims

CMS Unveils New Prior Authorization "WISeR Model" For Electrical Nerve Stimulators, Skin And Tissue Substitutes And Knee Arthroscopy

United States Healthcare

KM

Katten Muchin Rosenman LLP

June 2025 Newsletter

Worldwide International

BG

Braumiller Law Group, PLLC

Avoid Costly Mistakes: Insights From Recent ERP Legal Battles (Video)

United States Technology

TS

Taft Stettinius & Hollister

Should We Expect More Tariffs In The Future? Understanding Trump's America First Trade Policy

United States International

BG

Braumiller Law Group, PLLC

U.S.-China Trade Relations: An Update On Tariffs

United States International

BG

Braumiller Law Group, PLLC

All Is Fair In Love And War, But Apparently Not Trade - Closing The Gap On Global Trade Deficits With The U.S. (A Monumental Task For A Variety Of Reasons)

United States International

BG

Braumiller Law Group, PLLC

Hot Topics In HIPAA

As public-facing representations, inaccurate Notices of Privacy Pracধces ("NPP") can provide a basis for decepধve or unfair trade pracধces or unfair compeধধon claims, including under the FTC Act.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Harnessing Synthetic Biology And Genome Editing To Combat Global Hunger

Over the past two decades, genetic engineering, synthetic biology, and bioinformatics have revolutionised plant science. In this Insight, we explore how recent advances in plant biotechnology...

United States Healthcare

JA

J A Kemp LLP

BIOTech Caucus Will Advance Domestic Bioeconomy And Competitive Posture

On June 26, 2025, Representatives Chrissy Houlahan (D-PA) and Stephanie Bice (R-OK) announced the formation of the BIOTech Caucus. According to Houlahan's June 26, 2025, press release, the Caucus' mission...

United States Healthcare

BC

Bergeson & Campbell

NIA Issues Position Paper On Divergent EU Approaches To Nano And Advanced Materials

On June 11, 2025, the Nanotechnology Industries Association (NIA) published a position paper entitled Bridging the Governance Gap: Divergent EU Approaches to Nano and Advanced Materials that highlights...

United States Healthcare

BC

Bergeson & Campbell

Health Headlines: June 2025

United States Healthcare

GP

Goodwin Procter LLP

Dental/DSO Industry Newsletter

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Fourth Circuit To Decide Opioids Public Nuisance Appeal After West Virginia's Highest Court Declines Certified Question

United States Healthcare

D

Dechert

BioNTech Announces Transaction To Acquire CureVac

United States Healthcare

GP

Goodwin Procter LLP

HHS To Launch Campaign Promoting Wearable Devices

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

NASEM Will Hold Workshop On Synthetic Biology For Biomanufacturing And Predictable Engineering On July 1, 2025

United States Healthcare

BC

Bergeson & Campbell

Oregon Enacts Limitations On PE Investment In Physician Practices

United States Commercial

TS

Taft Stettinius & Hollister

EU Restricts Chinese Access To Public Procurement Of Medical Devices

Worldwide Government

AO

A&O Shearman

Critical Medical Device Series: Part V Mitigating Litigation Risks For AI-Enabled Or Assisted Medical Devices (Video)

United States Healthcare

AP

Arnold & Porter

How IP Can Power The AI-driven Cleantech Revolution

United States Technology

BB

Baker Botts LLP

Oregon Enacts Limitations On PE Investment In Physician Practices

The most recent and stringent legislative effort to restrict private equity investment in medical practices became law on June 9, 2025, when Oregon Gov. Tina Kotek signed Senate Bill 951 (SB 951).

United States Commercial

TS

Taft Stettinius & Hollister

EU Restricts Chinese Access To Public Procurement Of Medical Devices

Last Friday, the European Commission announced its first International Procurement Instrument (IPI) measure, excluding "economic operators" from China from participation in EU public procurement procedures...

Worldwide Government

AO

A&O Shearman

Critical Medical Device Series: Part V Mitigating Litigation Risks For AI-Enabled Or Assisted Medical Devices (Video)

The number of artificial intelligence- and machine learning-enabled medical devices being used in the healthcare industry is increasing by the month, with the U.S. Food and Drug Administration having already authorized...

United States Healthcare

AP

Arnold & Porter

How IP Can Power The AI-driven Cleantech Revolution

The convergence of artificial intelligence (AI) and clean technology (cleantech) is rapidly transforming industries across the globe.

United States Technology

BB

Baker Botts LLP

Holland & Knight Health Dose: June 24, 2025

United States Healthcare

HK

Holland & Knight

Leveraging Technology To Create A Next Generation Academic Medical Center In Austin (Video)

How can a leading health system leverage technology to become a next-generation academic medical center — delivering world-renowned care...

United States Technology

AM

Alvarez & Marsal

The Geopolitical Race In Biotechnology

Innovation in cutting-edge technologies is redefining the foundations of national power, providing nations with the capacity to revolutionize systems...

Worldwide Healthcare

SJ

Steptoe LLP

Focusing On Compliance: Key Takeaways From The Pharma And Medical Device Panel At Porzio, Bromberg & Newman's Life Sciences Symposium

At a time when healthcare compliance demands in the life sciences industry remain complex, with an ongoing level of scrutiny from a public and governmental perspective, a standout session...

United States Commercial

PB

Porzio, Bromberg & Newman

Delaware Court Awards More Than $180 Million For Breach Of Commercially Reasonable Efforts Obligation In Drug Development Milestone Dispute

On June 11, 2025, the Delaware Court of Chancery found Alexion Pharmaceuticals liable for more than $180 million in damages to former stockholders...

United States Commercial

GP

Goodwin Procter LLP

Northern District Of California Narrows Claims In Securities Class Action Against Medical Devices Company

United States Commercial

AO

A&O Shearman

FDA To Overhaul Post-Market Chemical Review Program For Food Chemicals

United States Healthcare

BD

Beveridge & Diamond

NSCEB Roadshow Highlights Biotechnology Across America

United States Healthcare

BC

Bergeson & Campbell

FDA Convenes Panel Evaluating The Role Of Talc As A Food Additive

United States Healthcare

D

Dechert

June 2025: Strategic Opportunities In The Life Sciences Sector

United States Healthcare

D

Dechert

Healthcare Private Equity Soon To Face Significant Hurdles In Oregon

United States Healthcare

D

Dechert

State Board Of Pharmacy: Ohio GLP-1 Compounders Be Vigilant

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

GT Newsletter | Competition Currents | June 2025

Worldwide Anti-trust

GT

Greenberg Traurig, LLP

HHS Announces Release Of MAHA Report

United States Healthcare

BC

Bergeson & Campbell

The Family CNA Model: Supporting Families And Improving Care For Children With Medical Complexity

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Fate Of LDT Final Rule Sealed As Appeal Deadline Passes

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Holland & Knight Health Dose: June 10, 2025

United States Healthcare

HK

Holland & Knight

FDA In Flux — June 2025 Newsletter

United States Healthcare

M

Mintz

PFAS Lawsuits On The Rise: Trends, Risks & Takeaways

United States Energy

SJ

Steptoe LLP

Take Care When Paying Volume-Based Compensation To Sales Agents To Avoid Anti-Kickback Statute Violations

United States Healthcare

DM

Duane Morris LLP

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

ADR And Diversity In The Life Sciences Sector

United States Commercial

J

JAMS

Latest Videos

See more

Leveraging Technology To Create A Next Generation Academic Medical Center In Austin (Video)

AM

Alvarez & Marsal

Life Science Dealmaking Trends 2025 (Video)

M

Mintz

Welcome: Judith Hasko (Video)

W

WilmerHale

Intellectual Property Partner Jason Murata In Conversation With The Hsu Untied Podcast (Video)

AV

Axinn Veltrop & Harkrider

Innovation In Biotech And AI (Video)

FL

Foley & Lardner

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More